There is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management, and outcomes of TGD persons with breast cancer in effort to identify opportunities for future intervention studies to eliminate breast cancer disparities for this population.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Breast Cancer Diagnosis Method
Timeframe: 33 years
Breast Cancer Risk Factors
Timeframe: 33 years
Breast Cancer Management Strategies
Timeframe: 33 years
Outcomes Data
Timeframe: 33 years